Suppr超能文献

[M1巨噬细胞中通过坏死性凋亡介导炎症细胞死亡的分子机制]

[Molecular Mechanism Underlying Inflammatory Cell Death via Necroptosis in M1 Macrophages].

作者信息

Koike Atsushi

机构信息

Department of Pathobiochemistry, Osaka University of Pharmaceutical Sciences.

出版信息

Yakugaku Zasshi. 2020;140(12):1427-1432. doi: 10.1248/yakushi.20-00161.

Abstract

M1 macrophages, also known as inflammatory macrophages, play an important role in the innate and adaptative immune responses against pathogens. However, the overactivation of these macrophages leads to the development and progression of various inflammatory diseases. Thus, the regulation of these macrophages is necessary to prevent such diseases. Necroptosis, a programmed form of necrosis, induces several damage-associated molecular patterns, such as high-mobility group box 1, adenosine triphosphate, and mitochondrial DNA, which activate various immune cells, thus leading to inflammation. Recent studies have shown that necroptosis in M1 macrophages is associated with inflammation in many pathological conditions. However, the molecular mechanisms underlying necroptosis in M1 macrophages are not completely understood. Thus, we examined the effects of a broad-spectrum caspase inhibitor, zVAD-fmk, on cell death in lipopolysaccharide (LPS)-induced M1 macrophages. Necrostatin-1, an inhibitor of necroptosis, partially inhibited zVAD-fmk-induced cell death and phosphorylation of mixed lineage kinase domain-like protein (MLKL) in M1 macrophages. Moreover, the inhibition of generation of reactive oxygen species (ROS) and activation of p38 mitogen-activated protein kinase (MAPK) reduced zVAD-fmk-induced necroptosis in M1 macrophages. Furthermore, the inhibition of ROS generation suppressed the activation of MLKL and p38 MAPK in zVAD-fmk-treated M1 macrophages. These results indicate that zVAD-fmk-induced cell death occurs via necroptosis through ROS-mediated activation of MLKL and p38 MAPK in M1 macrophages. Unraveling the molecular mechanisms of necroptosis in M1 macrophages might help understand their significance in inflammatory diseases.

摘要

M1巨噬细胞,也被称为炎性巨噬细胞,在针对病原体的固有免疫和适应性免疫反应中发挥着重要作用。然而,这些巨噬细胞的过度激活会导致各种炎性疾病的发生和发展。因此,对这些巨噬细胞进行调控对于预防此类疾病是必要的。坏死性凋亡是一种程序性坏死形式,可诱导多种损伤相关分子模式,如高迁移率族蛋白B1、三磷酸腺苷和线粒体DNA,这些分子会激活各种免疫细胞,从而导致炎症。最近的研究表明M1巨噬细胞中的坏死性凋亡与许多病理状况下的炎症有关。然而,M1巨噬细胞中坏死性凋亡的分子机制尚未完全明确。因此,我们研究了广谱半胱天冬酶抑制剂zVAD-fmk对脂多糖(LPS)诱导的M1巨噬细胞死亡的影响。坏死性凋亡抑制剂Necrostatin-1可部分抑制zVAD-fmk诱导的M1巨噬细胞死亡以及混合谱系激酶结构域样蛋白(MLKL)的磷酸化。此外,抑制活性氧(ROS)生成和p38丝裂原活化蛋白激酶(MAPK)激活可减少zVAD-fmk诱导的M1巨噬细胞坏死性凋亡。此外,抑制ROS生成可抑制zVAD-fmk处理的M1巨噬细胞中MLKL和p38 MAPK的激活。这些结果表明,zVAD-fmk诱导的细胞死亡是通过ROS介导的MLKL和p38 MAPK激活在M1巨噬细胞中经由坏死性凋亡发生的。阐明M1巨噬细胞中坏死性凋亡的分子机制可能有助于理解其在炎性疾病中的意义。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验